MedPath

NP-000888

Generic Name
NP-000888

Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis

Phase 2
Completed
Conditions
Psoriasis
Interventions
Drug: Vehicle
First Posted Date
2016-12-16
Last Posted Date
2018-06-12
Lead Sponsor
Galderma R&D
Target Recruit Count
61
Registration Number
NCT02995473
Locations
🇨🇳

Galderma investigational site 5, Taipei, Taiwan

🇨🇳

Galderma Investigational Site, Lincuo, Taoyuan, Taiwan

🇨🇳

Galderma investigational site, Tainan, Taiwan

and more 5 locations
© Copyright 2025. All Rights Reserved by MedPath